Incubation of Escherichia coli (104 organisms per ml) in cell-free rabbit lung lavage for 30 min at 37°C resulted in a 70% reduction in colony counts on deoxycholate agar. A low-molecular-weight peptide (about 3,400 daltons), with zinc as a cofactor, was responsible for this activity. The peptide was isolated by Sephadex G-15 separation of lyophilized rabbit lung lavage which had been centrifuged to remove macrophages and suspended phosphlipids and passed through a 10,000-dalton (pore size) membrane filter. Peptide activity against E. coli was inhibited by phosphate buffer but not by borate, Tris, or barbital buffer. Bacteria incubated in phosphate buffer and then washed in saline were resistant to peptide activity. Antibacterial activity was also inhibited when peptide-exposed bacteria were incubated in phosphate buffer before deoxycholate treatment. 32P-radiolabeled E. coli cells lost about 20% of their radiolabel after 15 min of incubation with peptide.
We have recently described an antibacterial system that was found in normal rabbit lung lavage and that damages Escherichia coli cells (6) . In our previous study, fractionation of lung lavage led to the identification of a lowmolecular-weight peptide which mediated this antibacterial activity. Peptide activity was stable at acid and alkaline pH values and at 95°C but was reversed with 10-4 M EDTA. Cell damage was characterized by the failure of lavageexposed bacteria to multiply on deoxycholate agar, and electron photomicrographs confirmed bacterial damage (6) .
The purpose of this paper is to further characterize this peptide and to show that peptide damage to bacteria is dependent on zinc and is associated with release of phosphorus from E. coli and that phosphate can reverse antibacterial activity.
MATERIALS AND METHODS Isolation of peptide from rabbit lung lavage. Techniques used to harvest and process rabbit lung lavage have been described previously (6) . Briefly, New Zealand rabbits weighing 2 to 4 kg each were sacrificed, and their lungs were lavaged with three 50-ml volumes of physiological saline. Macrophages and the surfactant pellet were removed by centrifugation, and the supernatant was passed through a PM 10 membrane filter (Amicon Corp., Lexington, Mass.). The ultrafiltrate was lyophilized and separated on a Sephadex G-15 column (Pharmacia Fine Chemicals, Inc., Piscataway, N.J.).
Our initial column separations were done in distilled water or 0.01 M ammonium acetate (6) , although more recently we used 0.01 M acetic acid. We currently pool and lyophilize ultrafiltrate from three rabbits and pass the material on a Sephadex G-15 column (2.5 by 50 cm) with 0.01 M acetic acid at an elution rate of 36 ml/h. Individual 3-ml fractions are read at 220 nm with a Beckman model 25 spectrophotometer.
The initial separation yielded a sharp, early peak, a small second peak, and a later, broad peak (Fig. 1) . The second and third peaks were heavily contaminated with salt. The third peak was desalted by repassing it on a Sephadex G-15 To ensure that controls for these experiments reflected as closely as possible the major cation composition of ultrafiltrate samples, we measured eight ultrafiltrates for calcium, magnesium, and zinc by use of a Perkin-Elmer 305 B atomic absorption spectrophotometer. Calcium and magnesium concentrations averaged about 4 x 10-5 and 1 x 10-5 M, respectively, whereas zinc levels were usually less than 1 ,ug/ml. Consequently, 0.15 M saline with 4 x 10-5 M calcium and 1 x 10-4 M magnesium, termed artificial ultrafiltrate, was used as the control solution for these studies.
Statistical analysis. Arithmetic means and standard deviations were calculated, and comparisons were made by the Student t test. RESULTS Results of Sephadex G-15 separation of lyophilized ultrafiltrate are shown in Fig. 1 . Original separation yielded three peaks which were designated peak 1 (P1), peak 2 (P2), and peak 3 (P3). Protein measurements showed that about 75% of biuret protein was located in P1. Pooled ultrafiltrate from three rabbits yielded 300 to 600 ,ug of P1. In about half the runs, only P1 and P3 were seen. When the broad P3 was desalted by repassing on Sephadex G-15 with 10 mM ammonium acetate, three peaks were recovered and, when P1 from this second pass was then passed on 10 mM acetic acid, it eluted at the same position as did the original P1. Con- The buffers chosen for activity studies proved to be important. All buffers which contained phosphate interfered with peptide activity against E. coli, whereas barbital, Tris, and acetate buffers all supported peptide activity against E. coli (Table 1 ). The type of phosphate buffer also seemed to be important; sodium phosphate was more active in reversing peptide activity than was potassium phosphate, suggesting that the cation present could also influence the rate of reversal of peptide activity. Addition of glucose did not enhance reversal.
Calcium enhanced the reversal of peptide damage by phosphate (Fig. 2) not at 4°C (Table 2) . Bacteria previously held in phosphate buffer and then washed in saline (phosphate-loaded) were more resistant to the antibacterial activity of peptide than were bacteria held in saline (Table 3) .
Zinc was an important cofactor for peptide antibacterial activity. EDTA at 10-5 M always reversed ultrafiltrate activity, and activity in EDTA-treated ultrafiltrate could be reconstituted with the addition of 10-5 M zinc but not with equimolar concentrations of calcium or magnesium (Table  4 ).
E. coli organisms labeled with 32p lost radiolabel when exposed to peptide (Fig. 3) , and about one-third of the radiolabel was recovered in supernatant after 30 min of incubation with peptide. Release of radiolabel into the supernatant was associated with bacterial damage, as evidenced by the failure of peptide-damaged bacteria to grow on deoxycholate agar. Recovery of bacterial radiolabel was dose related. An increase in the concentration of peptide from 5 to 20 ,ug/ml led to progressive increases in supernatant radiolabel after 30 min of incubation. DISCUSSION Pulmonary antibacterial defenses depend on integrated activity of respiratory reflexes, mucociliary clearance, lung phagocytes, and the immune status of the lung (3, 8) . The role of lung secretions other than immunoglobulins in overall lung antibacterial defenses has been a subject of controversy. Early studies have suggested that surfactant does not have direct antibacterial activity, since growth of E. coli, Streptococcus viridans, and Staphylococcus aureus in dog (4, 5) . These concepts are now being reevaluated as a result of new and exciting studies by Coonrod and Yoneda (1), who have shown that rat surfactant has profound pneumococcidal activity by stimulating pneumococcal autolysin. This activity is somewhat labile, which probably explains why this antimicrobial action was missed in earlier studies. These investigators have also shown that rat surfactant also has important antibacterial activity against several nonpneumococcal, gram-positive bacteria. Their studies have also demonstrated that a lysophospholipid, palmitoyl lysophosphatidyl choline, has many of the properties seen in the studies on raw surfactants. These data have reopened the proposition that pulmonary lysophospholipids have important antibacterial activity.
Lehrer and co-workers have recently characterized two microbicidal cationic proteins from rabbit alveolar macrophages. Alveolar macrophages were mechanically disrupted by centrifugation at 27,000 x g, and a supernatant fraction was extracted with citric acid, which yielded two cationic protein bands. These proteins had maximum antimicrobial activity against Candida spp. and intermediate activity against gram-positive organisms but were inactive against gram-negative rods (9) . These peptides have been purified, and amino acid analysis has shown them to be rich in arginine and half-cystine (10) . It is likely that these proteins play an important role in the intracellular killing of Candida spp. Whether these peptides are secreted and exist freely in the acellular fraction of lung lavage is currently not known.
Our studies have shown that normal rabbit lavage contains a complex antibacterial system which damages E. coli organisms. Fractionation of lung lavage yielded a low-molecularweight protein which had antibacterial activity and needed zinc as a cofactor. Evidence for the importance of zinc stemmed from EDTA studies of ultrafiltrate, in which it was shown that zinc could reconstitute activity in EDTA-treated specimens, a phenomenon not seen with calcium or magnesium.
The similarity between this peptide and an antimicrobial system in amniotic fluid is striking (13) . Amniotic fluid samples collected from women at 36 to 40 weeks of gestation were all bactericidal or bacteriostatic against E. coli (11). The inhibitor was heat stable and sensitive to phosphate and was removed after absorption with bentonite (12, 13). Moredetailed biochemical studies identified the bacterial inhibitor as a low-molecular-weight (630) peptide which required the metal cation zinc. The peptide was inactivated by digestion with carboxypeptidase, and the amino acid composition of the peptide was 3-glutamine-glutamic acid, 1 glycine and 1 lysine (13) . Our experimental data are quite similar to those reported in amniotic fluid studies and suggest that lowmolecular-weight antibacterial peptides may be broadly distributed.
Phosphate reversal of antibacterial activity was impressive, although not surprising, since several antibacterial peptides have been shown to be sensitive to phosphate (10, 13) . Phosphate alone at concentrations greater than 0.05 M sufficed to reverse peptide damage. Addition of calcium, however, markedly decreased the level of phosphate necessary to reverse peptide activity. The mechanism involved in this reversal of activity is not shown. Failure to protect at 40C suggests that the effect is not simply one of cation absorption to E. coli cell walls or membranes. Leakage of 32p from peptide-treated E. coli organisms is consistent with membrane damage, and electron microscopy studies of peptide-treated E. coli organisms have shown evidence consistent with leakage of intracellular contents (6) .
To date, we have been unable to produce a specific antibody to this peptide. Until such an antibody is produced, it will be difficult to quantitate the role that this antibacterial system plays in in situ antibacterial activity in the lung. 
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